Global Continuous Glucose Monitoring (CGM) Market Research Report 2022
A continuous glucose monitor is a device used for monitoring blood glucose on a continual basis by people with type I diabetes.
Due to the COVID-19 pandemic, the global Continuous Glucose Monitoring (CGM) market size is estimated to be worth US$ 12590 million in 2021 and is forecast to a readjusted size of US$ 18670 million by 2028 with a CAGR of 5.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Continuous Glucose Monitoring (CGM) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Continuous Glucose Monitoring (CGM) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
A continuous glucose monitor takes a reading on set intervals with a small electrode placed under the skin and held in place by an adhesive. A transmitter attached to the electrode sends data to a separate receiver.
This report focuses on Continuous Glucose Monitoring (CGM) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Continuous Glucose Monitoring (CGM) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Continuous Glucose Monitoring (CGM) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Transmitters
Sensors
Insulin Pumps
Segment by Application
Hospitals
Homecare Settings
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Due to the COVID-19 pandemic, the global Continuous Glucose Monitoring (CGM) market size is estimated to be worth US$ 12590 million in 2021 and is forecast to a readjusted size of US$ 18670 million by 2028 with a CAGR of 5.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Continuous Glucose Monitoring (CGM) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Continuous Glucose Monitoring (CGM) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
A continuous glucose monitor takes a reading on set intervals with a small electrode placed under the skin and held in place by an adhesive. A transmitter attached to the electrode sends data to a separate receiver.
This report focuses on Continuous Glucose Monitoring (CGM) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Continuous Glucose Monitoring (CGM) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Continuous Glucose Monitoring (CGM) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Transmitters
Sensors
Insulin Pumps
Segment by Application
Hospitals
Homecare Settings
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Pfizer
Baxter
Abbott Laboratories
Medtronic
Animas
Novo Nordisk
Ypsomed
GlySens
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
